Bionano Genomics, Inc. (BNGO) Stock Analysis

AI analysis of Bionano Genomics, Inc. (BNGO)

Hold

Bionano Genomics Inc (BNGO) is currently trading at $1.135, which is near its 52-week low of $1.00. The stock has a low RSI of 42.064, indicating it is not yet oversold, and the forward P/E ratio is 0, suggesting uncertainty in future earnings. While the gross margin has improved to 52.80% in Q2 2026, the company continues to report significant net losses, with a net income of -$7,423,000 for the same quarter. The upcoming earnings report on November 10, 2026, could provide further insights into its financial health, but currently, the stock shows mixed signals with a recent 5-day change of -1.30%.

Analyst Ratings (2)

+560.79% upside

Buy

2 Buy

0 Hold

0 Sell

Current: 1.14

Low

7.00

Average

7.50

High

8.00

H.C. Wainwright

Buy

$6

2026-04-13

H.C. Wainwright

2026-04-13

Price Target

$6

Buy

H.C. Wainwright

Buy

$7

2025-11-24

H.C. Wainwright

2025-11-24

Price Target

$7

Buy

H.C. Wainwright

Buy

$11

2025-08-18

H.C. Wainwright

2025-08-18

Price Target

$11

Buy

Maxim

Buy

$8

2025-05-20

Maxim

2025-05-20

Price Target

$8

Buy

HC Wainwright & Co.

Strong Buy

$10

2025-04-09

HC Wainwright & Co.

2025-04-09

Price Target

$10

Strong Buy

See All Ratings

Valuation Metrics

The current forward P/E ratio for Bionano Genomics, Inc. (BNGO) is 0.00, compared to its 5-year average forward P/E of -2.35.

Forward P/E

Fair

5Y Average P/E

-2.35

Current P/E

0.00

Overvalued

0.45

Undervalued

-5.16

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-1.55

Current EV/EBITDA

-0.66

Overvalued

0.72

Undervalued

-3.81

Forward P/S

Fair

5Y Average P/S

6.56

Current P/S

0.37

Overvalued

16.62

Undervalued

-3.49

Alphio AI Price Scenarios for BNGO

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BNGO

$3.64

Scenario price

B

Base

Base · 50%BNGO

$2.86

Scenario price

B

Bear

Bear · 25%BNGO

$2.26

Scenario price

BNGO FAQ — answered by Alphio AI

Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV). It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Bionano Genomics Inc (BNGO) is currently trading at $1.135, which is near its 52-week low of $1.00. The stock has a low RSI of 42.064, indicating it is not yet oversold, and the forward P/E ratio is 0, suggesting uncertainty in future earnings. While the gross margin has improved to 52.80% in Q2 2026, the company continues to report significant net losses, with a net income of -$7,423,000 for the same quarter. The upcoming earnings report on November 10, 2026, could provide further insights into its financial health, but currently, the stock shows mixed signals with a recent 5-day change of -1.30%.

2 analysts cover BNGO: 2 rate it Buy, 0 Hold and 0 Sell. The average price target is 7.50.